Found: 121
Select item for more details and to access through your institution.
Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 9, p. 1365, doi. 10.3390/v16091365
- By:
- Publication type:
- Article
Antigenic competition in CD4<sup>+</sup> T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 519, p. 1, doi. 10.1126/scitranslmed.aaw1673
- By:
- Publication type:
- Article
A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 419, p. 1, doi. 10.1126/scitranslmed.aan8848
- By:
- Publication type:
- Article
Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults.
- Published in:
- PLoS ONE, 2017, v. 12, n. 7, p. 1, doi. 10.1371/journal.pone.0179597
- By:
- Publication type:
- Article
In situ detection of Gag-specific CD8+ cells in the GI tract of SIV infected Rhesus macaques.
- Published in:
- Retrovirology, 2010, v. 7, p. 12, doi. 10.1186/1742-4690-7-12
- By:
- Publication type:
- Article
Whole genome sequencing of extreme phenotypes identifies variants in CD101 and UBE2V1 associated with increased risk of sexually acquired HIV-1.
- Published in:
- PLoS Pathogens, 2017, v. 13, n. 11, p. 1, doi. 10.1371/journal.ppat.1006703
- By:
- Publication type:
- Article
Mucosal effects of tenofovir 1% gel.
- Published in:
- eLife, 2015, p. 1, doi. 10.7554/eLife.04525.001
- By:
- Publication type:
- Article
CXCR3 enables recruitment and site-specific bystander activation of memory CD8<sup>+</sup> T cells.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-12980-2
- By:
- Publication type:
- Article
COVID-19 and the Path to Immunity.
- Published in:
- 2020
- By:
- Publication type:
- journal article
First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study.
- Published in:
- PLoS ONE, 2022, v. 17, n. 10, p. 1, doi. 10.1371/journal.pone.0274906
- By:
- Publication type:
- Article
Association of T Cell Proliferative Responses and Phenotype with Virus Control in Chronic Progressive HIV-1 Disease.
- Published in:
- Journal of Infectious Diseases, 2004, v. 189, n. 3, p. 515, doi. 10.1086/381038
- By:
- Publication type:
- Article
Moving to Human Immunodeficiency Virus Type 1 Vaccine Efficacy Trials: Defining T Cell Responses As Potential Correlates of Immunity.
- Published in:
- Journal of Infectious Diseases, 2003, v. 187, n. 2, p. 226, doi. 10.1086/367702
- By:
- Publication type:
- Article
Human Immunodeficiency Virus-Specific and CD3-Redirected Cytotoxic T Lymphocyte Activity in the Human Female Reproductive Tract: Lack of Correlation between Mucosa and Peripheral Blood.
- Published in:
- Journal of Infectious Diseases, 2001, v. 183, n. 6, p. 977, doi. 10.1086/319253
- By:
- Publication type:
- Article
Alterations in T Cell Phenotype and Human Immunodeficiency Virus Type 1-Specific Cytotoxicity after Potent Antiretroviral Therapy.
- Published in:
- Journal of Infectious Diseases, 2001, v. 183, n. 5, p. 722, doi. 10.1086/318816
- By:
- Publication type:
- Article
Two Double-Blinded, Randomized, Comparative Trials of 4 Human Immunodeficiency Virus Type 1...
- Published in:
- Journal of Infectious Diseases, 2000, v. 182, n. 5, p. 1357
- By:
- Publication type:
- Article
Effect of Combination Antiretroviral Therapy on T-Cell Immunity in Acute Human Immunodeficiency...
- Published in:
- Journal of Infectious Diseases, 2000, v. 181, n. 1, p. 121, doi. 10.1086/315202
- By:
- Publication type:
- Article
A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8[sup+] Cytotoxic T Lymphocyte Responses in Seronegative Volunteers.
- Published in:
- Journal of Infectious Diseases, 1999, v. 180, n. 2, doi. 10.1086/314895
- By:
- Publication type:
- Article
Early and Persistent Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Helper Dysfunction in Blood and Lymph Nodes following Acute HIV-1 Infection.
- Published in:
- Journal of Infectious Diseases, 1999, v. 180, n. 2, doi. 10.1086/314868
- By:
- Publication type:
- Article
Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV-1MN gp120, HIV-1SF2 Recombinant gp120, or Both Vaccines in Seronegative Adults.
- Published in:
- Journal of Infectious Diseases, 1998, v. 177, n. 5, p. 1230
- By:
- Publication type:
- Article
Analysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines.
- Published in:
- Journal of Infectious Diseases, 1998, v. 177, n. 2, p. 310, doi. 10.1086/514209
- By:
- Publication type:
- Article
Cytotoxic T Cell and Neutralizing Antibody Responses to Human Immunodeficiency Virus Type 1 Envelope with a Combination Vaccine Regimen.
- Published in:
- Journal of Infectious Diseases, 1998, v. 177, n. 2, p. 301, doi. 10.1086/514202
- By:
- Publication type:
- Article
Neutralization of a Clade B Primary Isolate by Sera from Human Immunodeficiency Virus-Uninfected Recipients of Candidate AIDS Vaccines.
- Published in:
- Journal of Infectious Diseases, 1997, v. 175, n. 4, p. 764
- By:
- Publication type:
- Article
Longitudinal Analysis of Quantitative Virologic Measures in Human Immunodeficiency Virus-Infected Subjects with ⩾400 CD4 Lymphocytes: Implications for Applying Measurements to Individual Patients.
- Published in:
- Journal of Infectious Diseases, 1997, v. 175, n. 2, p. 247
- By:
- Publication type:
- Article
Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1.
- Published in:
- Journal of Infectious Diseases, 1996, v. 173, n. 2, p. 340
- By:
- Publication type:
- Article
Determinants Of Antibody Response After Recombinant Gp160 Boosting In Vaccinia-Naive Volunteers Primed With Gp160-Recombinant Vaccinia Virus.
- Published in:
- Journal of Infectious Diseases, 1994, v. 170, n. 4, p. 782
- By:
- Publication type:
- Article
Immune responses elicited by recombinant vaccinia-human immunodeficiency virus (HIV) envelope and HIV envelope protein: analysis of the durability of responses and effect of repeated boosting.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Setting the stage: host invasion by HIV.
- Published in:
- 2008
- By:
- Publication type:
- journal article
MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data.
- Published in:
- Genome Biology, 2015, v. 16, p. 1, doi. 10.1186/s13059-015-0844-5
- By:
- Publication type:
- Article
Most DC-SIGNR transcripts at mucosal HIV transmission sites are alternatively spliced isoforms.
- Published in:
- European Journal of Human Genetics, 2005, v. 13, n. 6, p. 707, doi. 10.1038/sj.ejhg.5201409
- By:
- Publication type:
- Article
Long-term Effect of Depot Medroxyprogesterone Acetate on Vaginal Microbiota, Epithelial Thickness and HIV Target Cells.
- Published in:
- Journal of Infectious Diseases, 2014, v. 210, n. 4, p. 651, doi. 10.1093/infdis/jiu176
- By:
- Publication type:
- Article
Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Toll-like Receptor Polymorphism Associations With HIV-1 Outcomes Among Sub-Saharan Africans.
- Published in:
- Journal of Infectious Diseases, 2014, v. 209, n. 10, p. 1623, doi. 10.1093/infdis/jit807
- By:
- Publication type:
- Article
Vaccine-Induced Gag-Specific T Cells Are Associated With Reduced Viremia After HIV-1 Infection.
- Published in:
- Journal of Infectious Diseases, 2013, v. 208, n. 8, p. 1231, doi. 10.1093/infdis/jit322
- By:
- Publication type:
- Article
Characterization of Humoral and Cellular Immune Responses Elicited by a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine in Healthy Adults (IPCAVD 001).
- Published in:
- Journal of Infectious Diseases, 2013, v. 207, n. 2, p. 248, doi. 10.1093/infdis/jis671
- By:
- Publication type:
- Article
Quantifying ongoing HIV-1 exposure in HIV-1-serodiscordant couples to identify individuals with potential host resistance to HIV-1.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Quantifying Ongoing HIV-1 Exposure in HIV-1–Serodiscordant Couples to Identify Individuals With Potential Host Resistance to HIV-1.
- Published in:
- Journal of Infectious Diseases, 2012, v. 206, n. 8, p. 1299, doi. 10.1093/infdis/jis480
- By:
- Publication type:
- Article
Timing of Plasmid Cytokine (IL-2/Ig) Administration Affects HIV-1 Vaccine Immunogenicity in HIV-Seronegative Subjects.
- Published in:
- Journal of Infectious Diseases, 2011, v. 204, n. 10, p. 1541, doi. 10.1093/infdis/jir615
- By:
- Publication type:
- Article
A Trimeric, V2-Deleted HIV-1 Envelope Glycoprotein Vaccine Elicits Potent Neutralizing Antibodies but Limited Breadth of Neutralization in Human Volunteers.
- Published in:
- Journal of Infectious Diseases, 2011, v. 203, n. 8, p. 1165
- By:
- Publication type:
- Article
Host Genetic Determinants of T Cell Responses to the MRKAd5 HIV-1 gag/pol/nef Vaccine in the Step Trial.
- Published in:
- Journal of Infectious Diseases, 2011, v. 203, n. 6, p. 773, doi. 10.1093/infdis/jiq125
- By:
- Publication type:
- Article
Immune Responses to HIV Vaccines and Potential Impact on Control of Acute HIV-1 Infection.
- Published in:
- Journal of Infectious Diseases, 2010, v. 202, p. S323, doi. 10.1086/655658
- By:
- Publication type:
- Article
Conserved HIV-1 Epitopes Continuously Elicit Subdominant Cytotoxic T-Lymphocyte Responses.
- Published in:
- Journal of Infectious Diseases, 2009, v. 200, n. 12, p. 1825, doi. 10.1086/648401
- By:
- Publication type:
- Article
A Framework for Assessing Immunological Correlates of Protection in Vaccine Trials.
- Published in:
- Journal of Infectious Diseases, 2007, v. 196, n. 9, p. 1304, doi. 10.1086/522428
- By:
- Publication type:
- Article
Repeat-Region Polymorphisms in the Gene for the Dendritic Cell-Specific Intercellular Adhesion Molecule-3-Grabbing Nonintegrin- Related Molecule: Effects on HIV-1 Susceptibility.
- Published in:
- Journal of Infectious Diseases, 2006, v. 193, n. 5, p. 698, doi. 10.1086/499820
- By:
- Publication type:
- Article
High-Dose Recombinant Canarypox Vaccine Expressing HIV-1 Protein, in Seronegative Human Subjects.
- Published in:
- Journal of Infectious Diseases, 2005, v. 192, n. 7, p. 1249
- By:
- Publication type:
- Article
Demographic Factors That Influence the Neutralizing Antibody Response in Recipients of Recombinant HIV-1 gp120 Vaccines.
- Published in:
- Journal of Infectious Diseases, 2004, v. 190, n. 11, p. 1962
- By:
- Publication type:
- Article
Analysis of Genetic Polymorphisms in CCR5, CCR2, Stromal Cell--Derived Factor--1, RANTES, and Dendritic Cell--Specific Intercellular Adhesion Molecule--3--Grabbing Nonintegrin in Seronegative Individuals Repeatedly Exposed to HIV-1.
- Published in:
- Journal of Infectious Diseases, 2004, v. 190, n. 6, p. 1055, doi. 10.1086/423209
- By:
- Publication type:
- Article
Breakthrough Infections during Phase 1 and 2 Prime-Boost HIV-1 Vaccine Trials with Canarypox Vectors (ALVAC) and Booster Dose of Recombinant gp120 or gp160.
- Published in:
- Journal of Infectious Diseases, 2004, v. 190, n. 5, p. 903, doi. 10.1086/423284
- By:
- Publication type:
- Article
Comparison of Systemic and Mucosal Delivery of 2 Canarypox Virus Vaccines Expressing either HIV-1 Genes or the Gene for Rabies Virus G Protein.
- Published in:
- Journal of Infectious Diseases, 2004, v. 189, n. 7, p. 1221
- By:
- Publication type:
- Article
Identification of Effective Subdominant Anti-HIV-1 CD8+ T Cells Within Entire Post-infection and Post-vaccination Immune Responses.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 2, p. 1, doi. 10.1371/journal.ppat.1004658
- By:
- Publication type:
- Article
HIV-1 Vaccine-Induced T-Cell Reponses Cluster in Epitope Hotspots that Differ from Those Induced in Natural Infection with HIV-1.
- Published in:
- PLoS Pathogens, 2013, v. 9, n. 6, p. 1, doi. 10.1371/journal.ppat.1003404
- By:
- Publication type:
- Article